title: Perspectives on early communication of drug risks to the public.
authors.affiliation: Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. paul.seligman@fda.hhs.gov
authors.forename: P J
authors.initials: PJ
authors.lastname: Seligman
authors.forename: S F
authors.initials: SF
authors.lastname: Osborne
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000639:trends*; D003142:Communication; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D010353:Patient Education as Topic / Q000379:methods / Q000639:trends; D011634:Public Health / Q000379:methods / Q000639:trends*; D012307:Risk Factors